Lv7
4920 积分 2021-06-04 加入
Chimeric antigen receptor T-cell therapy - assessment and management of toxicities
23天前
已完结
Immune regulation by glucocorticoids
23天前
已完结
BCMA双特异性T细胞接合器治疗多发性骨髓瘤中国临床专家共识（2025年版）
24天前
已完结
Ifinatamab deruxtecan, a B7-H3-directed antibody–drug conjugate, in patients with advanced solid tumours (IDeate-PanTumor01): dose-escalation results from a phase 1/2 trial
4个月前
已完结
Ifinatamab deruxtecan, a B7-H3-directed antibody-drug conjugate, in patients with advanced solid tumours (IDeate-PanTumor01): dose-escalation results from a phase 1/2 trial
4个月前
已完结
Targeted Inhibition of CYP11A1 in Castration-Resistant Prostate Cancer
4个月前
已完结
Ifinatamab deruxtecan, a B7-H3-directed antibody-drug conjugate, in patients with advanced solid tumours (IDeate-PanTumor01): dose-escalation results from a phase 1/2 trial
4个月前
已完结
Prostate cancer statistics, 2025
5个月前
已完结
前列腺癌新辅助治疗与辅助治疗的现状及进展
7个月前
已完结
皖公网安备34019202002308
